» Authors » Sneha S Jain

Sneha S Jain

Explore the profile of Sneha S Jain including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 30
Citations 1470
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Bedi S, Jain S, Shah N
Nat Med . 2024 Jul; 30(9):2409-2410. PMID: 39060659
No abstract available.
12.
Perez-Guerrero E, Mehrotra I, Jain S, Perez M
Heart Rhythm . 2024 Jul; 22(2):579-584. PMID: 39053754
No abstract available.
13.
Perez-Guerrero E, Mehrotra I, Jain S, Perez M
Heart Rhythm . 2024 Jul; 22(2):572-578. PMID: 39053750
No abstract available.
14.
Somani S, Jain S, Sarraju A, Sandhu A, Hernandez-Boussard T, Rodriguez F
Commun Med (Lond) . 2024 Jul; 4(1):137. PMID: 38987347
Background: The prevalence of obesity has been increasing worldwide, with substantial implications for public health. Obesity is independently associated with cardiovascular morbidity and mortality and is estimated to cost the...
15.
Parsa S, Somani S, Dudum R, Jain S, Rodriguez F
Curr Atheroscler Rep . 2024 May; 26(7):263-272. PMID: 38780665
Purpose Of Review: This review evaluates how Artificial Intelligence (AI) enhances atherosclerotic cardiovascular disease (ASCVD) risk assessment, allows for opportunistic screening, and improves adherence to guidelines through the analysis of...
16.
Elias P, Jain S, Poterucha T, Randazzo M, Lopez Jimenez F, Khera R, et al.
J Am Coll Cardiol . 2024 Apr; 83(24):2472-2486. PMID: 38593946
Recent artificial intelligence (AI) advancements in cardiovascular care offer potential enhancements in diagnosis, treatment, and outcomes. Innovations to date focus on automating measurements, enhancing image quality, and detecting diseases using...
17.
Jain S, Elias P, Poterucha T, Randazzo M, Lopez Jimenez F, Khera R, et al.
J Am Coll Cardiol . 2024 Apr; 83(24):2487-2496. PMID: 38593945
Recent artificial intelligence (AI) advancements in cardiovascular care offer potential enhancements in effective diagnosis, treatment, and outcomes. More than 600 U.S. Food and Drug Administration-approved clinical AI algorithms now exist,...
18.
Jain S, Yu J, Arnott C, Neal B, Perkovic V, Neuen B, et al.
Int J Cardiol . 2023 Oct; 395:131444. PMID: 37844669
Background: Canagliflozin is a sodium-glucose cotransporter 2 inhibitor that has been shown to reduce cardiovascular events in diabetic patients with and without heart failure (HF). Whether the clinical benefits and...
19.
Carey M, Marshall D, Clerkin K, Laracuente R, Sanchez J, Jain S, et al.
J Heart Lung Transplant . 2023 Sep; 43(6):866-875. PMID: 37739242
Background: Aortic root thrombosis(ART) is a complication of continuous-flow left ventricular assist device therapy. However, the incidence and related complications of ART in HeartMate 3 (HM3) patients remain unknown. Methods:...
20.
Peng A, Dudum R, Jain S, Maron D, Patel B, Khandwala N, et al.
J Am Coll Cardiol . 2023 Sep; 82(12):1192-1202. PMID: 37704309
Background: Coronary artery calcium (CAC) is a strong predictor of cardiovascular events across all racial and ethnic groups. CAC can be quantified on nonelectrocardiography (ECG)-gated computed tomography (CT) performed for...